Table 1 Clinical features of patients with active SLE and patients with inactive SLE*
Characteristic | Patients with active disease | Patients with inactive disease |
|---|---|---|
| Â | (n = 36) | (n = 12) |
No. of men/no. of women | 5/31 | 2/10 |
Age, mean ± SD (range) years | 35 ± 14 (11--69) | 36 ± 12 (16--59) |
Disease duration, mean ± SD (range) months | 65 ± 101 (1--260) | 118 ± 98 (5--216) |
Disease activity | Â | Â |
   SLEDAI score (0--105), mean ± SD | 16 ± 4 | 7 ± 4 |
   Anti-dsDNA titer, mean ± SD IU/ml | 597 ± 784 | 49 ± 56 |
   CH50 level, mean ± SD units/ml | 14 ± 11 | 26 ± 8 |
Clinical manifestation | Â | Â |
   WHO class IV nephritis | 24 | 5 |
   Other than WHO class IV nephritis | 12 | 7 |
   CNS disease | 6 | 0 |
Treatment at time of study | Â | Â |
   None | 10 | 0 |
   ≤10 mg/day prednisolone | 28 | 9 |
   Immunosuppressive agents | 7 | 1 |